Therapeutic Angiogenesis Induced by Human Recombinant Hepatocyte Growth Factor in Rabbit Hind Limb Ischemia Model as Cytokine Supplement Therapy

Ryuichi Morishita(The University of Osaka), Toshio Ogihara(Osaka University), Kunio Matsumoto(Kanazawa University), Mutsuo Taiji(The Nakamura Hajime Eastern Institute), Tomokazu Nagano(The Nakamura Hajime Eastern Institute), Toshikazu Nakamura(The University of Osaka), Shinichiro Hayashi(The University of Osaka), Shigefumi Nakamura(The University of Osaka), Atsushi Moriguchi(The University of Osaka), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Hiroshi Noguchi(The Nakamura Hajime Eastern Institute), Satoshi Takeshita(The Nakamura Hajime Eastern Institute), Yoshiaki Taniyama(The University of Osaka)
Hypertension
June 1, 1999
10.1161/01.hyp.33.6.1379
Cited by 271

Related Papers

Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588